Questions About Cancer? 1-800-4-CANCER
  • Print
  • Facebook
  • Twitter
  • Google+
  • Pinterest

NCI Dictionary of Cancer Terms

yttrium Y 90 clivatuzumab tetraxetan  listen  (IH-tree-um … KLY-vuh-TOO-zoo-mab teh-TRAK-seh-tan)

  A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90 clivatuzumab tetraxetan contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90 clivatuzumab tetraxetan is a type of radioimmunoconjugate. Also called yttrium Y 90 DOTA monoclonal antibody HuPAM4.